When Bureaucrats Get Busy, Some Investors Might Get Wise
There are few things in life more certain than the ever-expanding maze of rules and regulations. I’ve always found it fascinating how, for every new rule created, an entire industry seems to pop up to help people navigate it. It’s the circle of life, but for paperwork. And right now, I think we’re seeing a prime example of this unfolding in the colossal, and frankly bewildering, world of American healthcare.
The starting pistol was fired when the US Department of Justice decided to take a long, hard look at UnitedHealth Group, the biggest beast in the healthcare jungle. The investigation is all about billing practices, which sounds dreadfully dull, but the implications are anything but. To me, this isn't just about one company’s potential headache. It’s a signal flare, warning the entire sector that the days of light-touch oversight may be well and truly over.